SYCN | Syncollin | Predicted secreted proteins
| | | | | Tissue enriched |
CELA3A | Chymotrypsin-like elastase family, member 3A | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CELA3B | Chymotrypsin-like elastase family, member 3B | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CTRC | Chymotrypsin C (caldecrin) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CEL | Carboxyl ester lipase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CTRL | Chymotrypsin-like | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CPA1 | Carboxypeptidase A1 (pancreatic) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
GP2 | Glycoprotein 2 (zymogen granule membrane) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
RBPJL | Recombination signal binding protein for immunoglobulin kappa J region-like | Transcription factors
| | | | | Tissue enriched |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PRSS1 | Protease, serine, 1 (trypsin 1) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
PNLIP | Pancreatic lipase | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPB1 | Carboxypeptidase B1 (tissue) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
CPA2 | Carboxypeptidase A2 (pancreatic) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AMY2A | Amylase, alpha 2A (pancreatic) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
PRSS3 | Protease, serine, 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
IAPP | Islet amyloid polypeptide | Predicted secreted proteins
| | | | | Tissue enriched |
SPACA3 | Sperm acrosome associated 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | | | | Group enriched |
PDIA2 | Protein disulfide isomerase family A, member 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
AMY2B | Amylase, alpha 2B (pancreatic) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PPY | Pancreatic polypeptide | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
ERP27 | Endoplasmic reticulum protein 27 | Predicted secreted proteins
| | | | | Tissue enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SPINK1 | Serine peptidase inhibitor, Kazal type 1 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | | | Group enriched |
PKHD1 | Polycystic kidney and hepatic disease 1 (autosomal recessive) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GCG | Glucagon | Predicted secreted proteins
| | | | | Tissue enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AC131097.4 | Protein LOC285095 | | | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
C8orf47 | Chromosome 8 open reading frame 47 | | | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
NKX6-1 | NK6 homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
NPHS1 | Nephrosis 1, congenital, Finnish type (nephrin) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |